Deb Neklason, Marcus Pezzolesi and John Bohnsack from the University of Utah are collaborating with Janssen Research and Development LLC to study colorectal cancer, diabetic…
Mark Yandell, PhD, Professor of Human Genetics and Co-Director of the USTAR Center for Genetic Discovery, along with University of Utah collaborators and fellow UGP…
BBC News reports on the latest technological device used to sequence the human genome.
Ryan Layer, Ph.D., senior postdoctoral fellow in Aaron Quinlan’s lab at the Department of Human Genetics at U of U Health and the USTAR Center for…
Aaron Quinlan, PhD, Associate Professor of Human Genetics and Co-Director of the USTAR Center for Genetic Discovery, and his graduate student, Tom Sasani, develop a…
Dr. Mark Yandell and collaborators, Drs. Martin Tristani-Firouzi and H. Joseph Yost, take part in a large national “Bench-to-Bassinet” NIH consortium to study congenital heart…
Yi Qiao, PhD, in the Department of Human Genetics and the USTAR Center for Genetic Discovery uses a computer algorithm to help clinicians treat cancer more effectively.
Watch this American Heart Association video of U of U researchers discussing the importance of understanding the causes of congenital heart disease.
Researchers at the U of U, in collaboration with Janssen Research and Development LLC, search genetic clues to better understand the relationship between suicidal behavior and psychiatric conditions.
Drs. Gabor Marth and Martin Tristani-Firouzi use a software tool, iobio, to assist doctors with providing clinical care based on information found within their patient’s DNA.
Mark Yandell, Ph.D., professor of human genetics and director of the USTAR Center for Genetic Discovery has created new tools, CAE and WARP, to uncover…
The Quinlan Laboratory is using the diminutive MinION genome sequencing device to study viral genome evolution.
Dr. Yandell and Dr. Quinlan from the USTAR Center for Genetic Discovery were awarded a grant from the American Heart Association to use innovative data science technologies to uncover the genetic and environmental causes of congenital heart disease.
Local news feature describing how The Utah Science, Technology, and Research (USTAR) Initiative of the state of Utah is promoting the growth of high tech industries in Utah.
Mark Yandell, PhD, discussed the roles that VAAST and PHEVOR played in launching the Utah Genome Project.
Using three different software technologies including pVAAST and VAAST, developed at the USTAR Center for Genetic Discovery at the University of Utah, investigators discovered a mutation in one gene, POLR2C, linked to a higher risk of premature menopause.
Base2 Genomics has won a USTAR Technology Acceleration award to commercialize their platform for whole genome diagnostics with proprietary technologies for accurate CNV and SV discovery and interpretation. Read more in this Gephart Daily local news feature.
This week’s report in New England Journal of Medicine of two unusual Utah Zika cases raises questions about Zika virus transmission and virulence. Read about it in this NPR news feature.
A Utah man died of Zika virus infection and passed the virus to his son who cared for him in the hospital, according to a new report published in…
Frameshift Labs, LLC announces that it has secured NIH support to develop commercial software for visually driven genome analysis.
Researchers at University of Utah and ARUP Laboratories describe the first Zika virus-related death in the US. Published yesterday in the New England Journal of Medicine.
IDbyDNA announces today that it has closed $9 million in Series A financing to develop its Taxonomer-based infectious disease diagnostic technologies.
University of Utah, a recognized leader in genetics, genomics, and bioinformatics, has launched a program to train a new generation of physicians and scientists in the theory and practice of genomic medicine.
In this Scope Radio Interview, Dr. Lynn Jorde and Dr. Eric Green discuss opportunities and challenges in Genomic Medicine.